Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
None listed
Sponsors
Department of Siddhant Darshan Faculty of Ayurveda Institute of Medical Sciences BHU
Department of Prasuti Tantra Stri Roga and Department of Obstetrics and Gynecology
Eligibility
Inclusion criteria
Inclusion criteria: 1. Married women of age group 21 to 40 years. 2. Women having complaint of excessive menstrual bleeding from three cycles or more than three cycles. 3. Patients willing to participate in above mentioned trial and giving informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients associated with any currently ongoing research study. 2. Patients having history of recent delivery or abortion. 3. Patients using any hormonal preparation. 4. Patients with any specific disease specially of chronic nature such as marked anaemia, T.B., hypertension , diabetes , hypo/hyper thyroidism, cardiac disease, renal disease, jaundice or any other disorders influencing general physical health and ultimately influencing menses. 5. Patients having organic lesion of reproductive system such as cervical erosion, benign or malignant growth, extensive cervical carcinoma, cervical polyp, recto-vaginal fistula, uterovaginal prolapse, endometriosis, tubercular endometritis etc. 6. Psychiatric patients. 7. Patients having any allergy to the drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment will be done on the basis of prepared proforma for assessment of subjective parameter This completely depends upon the symptomatology & its gradesTimepoint: 4 months duration divided into 4 followups of 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effect of Tranexa, To evaluate the effect of Shalmali Ghrit Uttar Basti,To evaluate the effect of Mocharasa ChurnaTimepoint: 4 months duration divided into 4 followups of 1 month | — |
Countries
India
Contacts
Public ContactProf Rani Singh
Banaras Hindu University
Outcome results
None listed